Business
AstraZeneca and Johnson & Johnson given green light to resume US coronavirus vaccine trials – ABC News
In a sign of progress in the race to develop a vaccine for COVID-19, AstraZeneca’s resumption of its US clinical trial is set to be soon followed by Johnson & Johnson…
AstraZeneca has resumed the US trial of its experimental COVID-19 vaccine after approval by regulators, and Johnson & Johnson is preparing to resume its trial early next week.
Key points:
- Both vaccine candidates had been forced to pause US trials after participant illnesses
- But both have been cleared to resume after it was found the vaccines were not the cause
- The race for a vaccine comes as coronavirus infections rise in dozens of countries
The news signalled progress against the novel coronavirus…
-
General18 hours agoA feeling of calm before the storm descends on Tasmanian politics following motion of no-confidence in Jeremy Rockliff
-
Noosa News21 hours agoTwo bodies found in search for missing Brisbane couple in Tasmania
-
Noosa News19 hours agoNow Open: The Force Is Strong with Australia’s First-Ever ‘Star Wars’ Cafe, Which Is Serving Up Blue Milk at Melbourne Museum
-
Noosa News16 hours agoForty years inside a Brisbane second-hand store